BATS BZX Real-Time Price
As of 1:23pm ET
| +0.07 / +1.14%|
The 6 analysts offering 12-month price forecasts for Endocyte Inc have a median target of 10.50, with a high estimate of 21.00 and a low estimate of 6.00. The median estimate represents a +69.35% increase from the last price of 6.20.
The current consensus among 7 polled investment analysts is to Buy stock in Endocyte Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.